AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46
Selective serotonin reuptake inhibitors for late-life depression - A comparative review
Authors: Solai, LKK Mulsant, BH Pollock, BG
Citation: Lkk. Solai et al., Selective serotonin reuptake inhibitors for late-life depression - A comparative review, DRUG AGING, 18(5), 2001, pp. 355-368
Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly
Authors: Bump, GM Mulsant, BH Pollock, BG Mazumdar, S Begley, AE Dew, MA Reynolds, CF
Citation: Gm. Bump et al., Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly, DEPRESS ANX, 13(1), 2001, pp. 38-44
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology
Authors: Schneider, LS Tariot, PN Lyketsos, CG Dagerman, KS Davis, KL Davis, S Hsiao, JK Jeste, DV Katz, IR Olin, JT Pollock, BG Rabins, PV Rosenheck, RA Small, GW Lebowitz, B Lieberman, JA
Citation: Ls. Schneider et al., National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology, AM J GER PS, 9(4), 2001, pp. 346-360
A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients
Authors: Mulsant, BH Pollock, BG Nebes, R Miller, MD Sweet, RA Stack, J Houck, PR Bensasi, S Mazumdar, S Reynolds, CF
Citation: Bh. Mulsant et al., A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients, AM J GER PS, 9(4), 2001, pp. 406-414
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers
Authors: Furlan, PM Kallan, MJ Ten Have, T Pollock, BG Katz, I Lucki, I
Citation: Pm. Furlan et al., Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers, AM J GER PS, 9(4), 2001, pp. 429-438
CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression
Authors: Murphy, GM Pollock, BG Kirshner, MA Pascoe, N Cheuk, W Mulsant, BH Reynolds, CF
Citation: Gm. Murphy et al., CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression, NEUROPSYCH, 25(5), 2001, pp. 737-743
Prevalence and risk of thrombocytopenia with valproic acid: Experience at a psychiatric teaching hospital
Authors: Conley, EL Coley, KC Pollock, BG DaPos, SV Maxwell, R Branch, RA
Citation: El. Conley et al., Prevalence and risk of thrombocytopenia with valproic acid: Experience at a psychiatric teaching hospital, PHARMACOTHE, 21(11), 2001, pp. 1325-1330
Dual-task performance in depressed geriatric patients
Authors: Nebes, RD Butters, MA Houck, PR Zmuda, MD Aizenstein, H Pollock, BG Mulsant, BH Reynolds, CF
Citation: Rd. Nebes et al., Dual-task performance in depressed geriatric patients, PSYCHIAT R, 102(2), 2001, pp. 139-151
Antipsychotic radioreceptor assay: A modification identifying selective receptor effects
Authors: Sweet, RA Henteleff, RA Meinert, KA DeMichele, MAA Kirshner, MA Sorisio, DA Pollock, BG
Citation: Ra. Sweet et al., Antipsychotic radioreceptor assay: A modification identifying selective receptor effects, THER DRUG M, 23(4), 2001, pp. 421-426
A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression inlate life
Authors: Mulsant, BH Sweet, RA Rosen, J Pollock, BG Zubenko, GS Flynn, T Begley, AE Mazumdar, S Reynolds, CF
Citation: Bh. Mulsant et al., A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression inlate life, J CLIN PSY, 62(8), 2001, pp. 597-604
Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults
Authors: Fabian, TJ Dew, MA Pollock, BG Reynolds, CF Mulsant, BH Butters, MA Zmuda, MD Linares, AM Trottini, M Kroboth, PD
Citation: Tj. Fabian et al., Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults, BIOL PSYCHI, 50(10), 2001, pp. 767-774
The 5-HTTPRS/*L polymorphism and aggressive behavior in Alzheimer disease
Authors: Sukonick, DL Pollock, BG Sweet, RA Mulsant, BH Rosen, J Klunk, WE Kastango, KB DeKosky, ST Ferrell, RE
Citation: Dl. Sukonick et al., The 5-HTTPRS/*L polymorphism and aggressive behavior in Alzheimer disease, ARCH NEUROL, 58(9), 2001, pp. 1425-1428
Alterations of striatal dopamine receptor binding in Alzheimer disease areassociated with Lewy body pathology and antemortem psychosis
Authors: Sweet, RA Hamilton, RL Healy, MT Wisniewski, SR Henteleff, R Pollock, BG Lewis, DA DeKosky, ST
Citation: Ra. Sweet et al., Alterations of striatal dopamine receptor binding in Alzheimer disease areassociated with Lewy body pathology and antemortem psychosis, ARCH NEUROL, 58(3), 2001, pp. 466-472
Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression
Authors: Whyte, EM Pollock, BG Wagner, WR Mulsant, BH Ferrell, RE Mazumdar, S Reynolds, CF
Citation: Em. Whyte et al., Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression, AM J PSYCHI, 158(12), 2001, pp. 2074-2076
Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms - A prospective double-blind study in depressed elderly patients
Authors: Mamo, DC Sweet, RA Mulsant, BH Pollock, BG Miller, MD Stack, JA Begley, AE Reynolds, CF
Citation: Dc. Mamo et al., Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms - A prospective double-blind study in depressed elderly patients, AM J GER PS, 8(3), 2000, pp. 226-231
Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline - A double-blind randomized trial
Authors: Weber, E Stack, J Pollock, BG Mulsant, B Begley, A Mazumdar, S Reynolds, CF
Citation: E. Weber et al., Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline - A double-blind randomized trial, AM J GER PS, 8(3), 2000, pp. 245-250
Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
Authors: Pollock, BG Ferrell, RE Mulsant, BH Mazumdar, S Miller, M Sweet, RA Davis, S Kirshner, MA Houck, PR Stack, JA Reynolds, CF Kupfer, DJ
Citation: Bg. Pollock et al., Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression, NEUROPSYCH, 23(5), 2000, pp. 587-590
Effect of paroxetine on plasma vasopressin and water load testing in elderly individuals
Authors: Marar, IE Towers, AL Mulsant, BH Pollock, BG Amico, JA
Citation: Ie. Marar et al., Effect of paroxetine on plasma vasopressin and water load testing in elderly individuals, J GER PSY N, 13(4), 2000, pp. 212-216
Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data
Authors: Wylie, ME Miller, MD Shear, MK Little, JT Mulsant, BH Pollock, BG Reynolds, CF
Citation: Me. Wylie et al., Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data, J GER PSY N, 13(1), 2000, pp. 43-48
Sertraline in the treatment of minor depression in nursing home residents:A pilot study
Authors: Rosen, J Mulsant, BH Pollock, BG
Citation: J. Rosen et al., Sertraline in the treatment of minor depression in nursing home residents:A pilot study, INT J GER P, 15(2), 2000, pp. 177-180
Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine
Authors: Chengappa, KNR Pollock, BG Parepally, H Levine, J Kirshner, MA Brar, JS Zoretich, RA
Citation: Knr. Chengappa et al., Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine, J CL PSYCH, 20(3), 2000, pp. 311-316
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
Authors: Pollock, BG Laghrissi-Thode, F Wagner, WR
Citation: Bg. Pollock et al., Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment, J CL PSYCH, 20(2), 2000, pp. 137-140
Pharmacologic profile of perphenazine's metabolites
Authors: Sweet, RA Pollock, BG Mulsant, BH Rosen, J Sorisio, D Kirshner, M Henteleff, R DeMichele, MAA
Citation: Ra. Sweet et al., Pharmacologic profile of perphenazine's metabolites, J CL PSYCH, 20(2), 2000, pp. 181-187
The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome
Authors: Hernandez, CR Smith, GS Houck, PR Pollock, BG Mulsant, B Dew, MA Reynolds, CF
Citation: Cr. Hernandez et al., The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome, PSYCHIAT R, 97(1), 2000, pp. 41-49
Free drug fraction versus free drug concentration - DeVane and Pollock reply
Authors: DeVane, CL Pollock, BG
Citation: Cl. Devane et Bg. Pollock, Free drug fraction versus free drug concentration - DeVane and Pollock reply, J CLIN PSY, 61(6), 2000, pp. 449-449
Risultati: 1-25 | 26-46